Atlas Trials

Ivonescimab With GnP and SBRT in Patients With Metastatic Pancreatic Cancer (WGOG-PAN 004)

Clinical trial NCT06991491 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06991491
Sponsor
West China Hospital
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Pancreatic Cancer
Start date
2025-06-01
Primary completion
2026-06-30
Enrollment
29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.